Ref. PDI/BK-BS-011/2019 25th February 2019 Re: Management Discussion and Analysis (MD&A) For the year ended December 31, 2018 To: President The Stock Exchange of Thailand Due to depletion of Mae Sod
Manager of the Stock Exchange of Thailand For the Q3/2019 period ended of September 30, 2019 (9 months) operating result of the company net loss Baht 0.22 Million comparison with the previous Q3/2018’s net
(the “Company”) would like to clarify in operating performance of year 2019 ended December 31st 2019. The Company’s net profit was Baht 133.38 Million which increased Baht 27.83 Million or 26.37
the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company
หนังสือแสดงการรับทราบความผิด 27 February 2020 Subject : Management Discussion and Analysis of the year ended 31 December 2019 Attn. : Director and Manager The Stock Exchange of Thailand Encls. : A
At Hor-For 0126/2550 August 8th, 2017 At Hor-For 0101/2560 Subject Notification of the performance of 2nd quarter ended June 30, 2017 Attn Directors and Manager, The Stock Exchange of Thailand We
“Company”) would like to clarify in operating performance for the 2nd quarter (three months period) ended June 30, 2017. The Company’s net profit was Baht 12.56 Million which decreased Baht 91.21 Million or
ABICO 011/KV/2017 August 10, 2017 Subject : Explanation on operation result for the Quarter ended June 30, 2017. To : Director and Manager Stock Exchange of Thailand Abico Holdings Public Company
/2017 period ended of June 30, 2017 operating result of the company net loss Baht 2.43 Million in comparison with the previous Q2/2016’s net loss of Baht 11.33 Million a decrease of loss Baht 8.90 Million